Schedule 13D ownership disclosure

AEVI GENOMIC MEDICINE INC

Security class unavailable · CUSIP: 00835P105

Event date: 2017-10-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
30.0800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-052850
Form type
SC 13D
Filer
Aevi Genomic Medicine, LLC
CIK
CIK 1138776
Filed
Oct 17, 2017
Reporting period
Oct 17, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub